Takeda Pharmaceutical Co., LTD et al v. Handa Pharmaceuticals, LLC

Filing 115

STIPULATION AND ORDER TO CORRECT THE COURT'S CLAIM CONSTRUCTION ORDER DUE TO A TRANSCRIPTION ERROR. Signed by Judge Joseph C. Spero on 5/31/12. (klhS, COURT STAFF) (Filed on 5/31/2012)

1

(All parties and counsel listed on Signature Page)

2
3
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION

4
5
6
7
8

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

9
10
11

14
15

Judge: Hon. Joseph C. Spero
v.
HANDA PHARMACEUTICALS, LLC,
Defendant.
TAKEDA PHARMACEUTICAL CO., LTD., Case No. 3:11-cv-01609-JCS
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

16
17
18
19

Plaintiffs,
v.
ANCHEN PHARMACEUTICALS, INC. AND
TWI PHARMACEUTICALS, INC.,
Defendant.

20
21
22
23

TAKEDA PHARMACEUTICAL CO., LTD., Case No. 3:11-cv-01610-JCS
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

24
25
26

STIPULATION TO CORRECT THE
COURT’S CLAIM CONSTRUCTION
ORDER DUE TO A TRANSCRIPTION
ERROR

Plaintiffs,

12
13

Case No. 3:11-cv-00840 JCS

Plaintiffs,
v.
IMPAX LABORATORIES, INC.,

27

Defendant.

28
Stipulation To Correct the Court’s Claim
Construction Order Due to a Transcription Error
Case Nos. 11-cv-0840-JCS, 11-cv-01609, 11-cv-01610
NYACTIVE-12579619.5

1

WHEREAS, the Court issued a claim construction order on April 11, 2012 (“Markman

2

Order,” Case No. 3:11-cv-00840, D.E. 106; Case No. 3:11-cv-01609, D.E. 81; Case No. 3:11-cv-

3

01610, D.E. 95);

4

WHEREAS, in its Markman Order the Court construed the term “soluble in the pH range

5

of no less than 6.5 to no more than 7.0,” found in claim 7 of U.S. Patent No. 7,790,755 (“the ’755

6

Patent”), to mean “begins to dissolve in the gastrointestinal tract at pH values within the range

7

from 6.0 to 7.5” (Markman Order at 71);

8
9
10

WHEREAS, this construction appears to have been the result of a transcriptional error;
and
WHEREAS, the Court appears to have instead intended for the term “soluble in the pH

11

range of no less than 6.5 to no more than 7.0” to mean “begins to dissolve at pH values within the

12

range from 6.5 to 7.0”;

13

The parties, by their undersigned attorneys, hereby stipulate, subject to the approval of the

14

Court, that the Markman Order should be corrected to reflect that the term “soluble in the pH

15

range of no less than 6.5 to no more than 7.0” means “begins to dissolve at pH values within the

16

range from 6.5 to 7.0”;

17

The parties, by their undersigned attorneys, further stipulate that this stipulation is entered

18

into solely for the purpose of correcting what appears to have been a transcriptional error in the

19

Markman Order and that nothing herein shall be construed as a waiver of the parties’ respective

20

positions with respect to claim construction.

21

Respectfully submitted,

22
23

DATED: May 30, 2012

HANDA PHARMACEUTICALS, LLC

24
By:
/s/ Mark T. Jansen
Mark T. Jansen (SBN 114896)
[e-mail]
CROWELL & MORING LLP
275 Battery St., 23rd Fl.
San Francisco, CA 94111
Telephone: [phone]

25
26
27
28

-2NYACTIVE-12579619.5

Stipulation To Correct the Court’s Claim
Construction Order Due to a Transcription Error
Case Nos. 11-cv-0840-JCS, 11-cv-01609, 11-cv-01610

1

Facsimile: [phone]

2

James K. Stronski
[e-mail]
Bruce D. DeRenzi
[e-mail]
Chiemi D. Suzuki
[e-mail]
Jacob Z. Zambrzycki
[e-mail]
CROWELL & MORING LLP
590 Madison Ave., 20th Fl.
New York, NY 10022-2524
Telephone: [phone]
Facsimile: [phone]

3
4
5
6
7
8
9

Keith J. Harrison
[e-mail]
Jennifer H. Burdman
[e-mail]
CROWELL & MORING LLP
1001 Pennsylvania Ave., N.W.
Washington, DC 20004-2595
Telephone: [phone]
Facsimile: [phone]

10
11
12
13
14

ANCHEN PHARMACEUTICALS, INC. and
TWI PHARMACEUTICALS, INC.

15
16
17

By:
/s/ Donald J. Mizerk
Donald J. Mizerk (SBN 208477)
[e-mail]
HUSCH BLACKWELL LLP
120 S. Riverside Plaza, 22nd Floor
Chicago, IL 60606
Telephone: [phone]
Facsimile: [phone]

18
19
20
21
22

IMPAX LABORATORIES, INC.

23
24

By:
/s/ Eric M. Acker
David C. Doyle (SBN 70690)
[e-mail]
Eric M. Acker (SBN 135805)
[e-mail]
Elizabeth Miller (SBN 250322)
[e-mail]
MORRISON & FOERSTER LLP

25
26
27
28

-3NYACTIVE-12579619.5

Stipulation To Correct the Court’s Claim
Construction Order Due to a Transcription Error
Case Nos. 11-cv-0840-JCS, 11-cv-01609, 11-cv-01610

1

12531 High Bluff Drive, Suite 100
San Diego, CA 92130-2040
Telephone: [phone]
Facsimile: [phone]

2
3

Parisa Jorjani (SBN 203487)
[e-mail]
MORRISON & FOERSTER LLP
425 Market Street, 32nd Floor
San Francisco, CA 94105
Telephone: [phone]
Facsimile: [phone]

4
5
6
7

Brian F. McMahon (SBN 235373)
[e-mail]
MORRISON & FOERSTER LLP
555 W. 5th Street, Suite 3500
Los Angeles, CA 90013
Telephone: [phone]
Facsimile: [phone]

8
9
10
11
12

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.

13
14
15
16

By:
/s/ Heather E. Takahashi
Jeffrey I. Weinberger (SBN 056214)
[e-mail]
Ted G. Dane (SBN 143195)
[e-mail]
Heather E. Takahashi (SBN 245845)
[e-mail]
Erin J. Cox (SBN 267954)
[e-mail]
MUNGER, TOLLES & OLSON LLP
355 South Grand Ave., 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]

17
18
19
20
21
22
23
24
25
26
27
28

-4NYACTIVE-12579619.5

Stipulation To Correct the Court’s Claim
Construction Order Due to a Transcription Error
Case Nos. 11-cv-0840-JCS, 11-cv-01609, 11-cv-01610

1

Filer’s Attestation

2

I, Mark Jansen, am the ECF user whose identification and password are being used to file

3

this STIPULATION TO CORRECT THE COURT’S CLAIM CONSTRUCTION ORDER

4

DUE TO A TRANSCRIPTION ERROR. In compliance with General Order 45.X.B., I hereby

5

attest that the other above-named signatories concur in this filing.

6

DATED: May 30, 2012
/s/ Mark T. Jansen

7
8

12

pero
ph C. S

NO

se
Judge Jo

14
15

A

H

ER

LI

RT

13

R NIA

Dated: May 31, 2012

FO

11

UNIT
ED

10

ISTRIC
ES D
TC
AT
T

RT
U
O

S

9

N

F
D IS T IC T O
R

C

16
17
18
19
20
21
22
23
24
25
26
27
28
-5NYACTIVE-12579619.5

Stipulation To Correct the Court’s Claim
Construction Order Due to a Transcription Error
Case Nos. 11-cv-0840-JCS, 11-cv-01609, 11-cv-01610